Supernus Pharmaceuticals, Inc.盘中异动大幅拉升7.17%

自选股智能写手04-23

北京时间2024年04月23日21时30分，Supernus Pharmaceuticals, Inc.（SUPN.us）股票出现异动，股价大幅拉升7.17%。截至发稿，该股报31.84美元/股，成交量847股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入6.08亿美元，净利润1.32百万美元，每股收益0.02美元，毛利4.39亿美元，市盈率1487.50倍。机构评级方面...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2429185761?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-23 21:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2429185761","market":"us","top_or_hot":-1,"title":"Supernus Pharmaceuticals, Inc.盘中异动 大幅拉升7.17%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年04月23日21时30分，Supernus Pharmaceuticals, Inc.（SUPN.us）股票出现异动，股价大幅拉升7.17%。截至发稿，该股报31.84美元/股，成交量847股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入6.08亿美元，净利润1.32百万美元，每股收益0.02美元，毛利4.39亿美元，市盈率1487.50倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232130317922ae9e&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Supernus Pharmaceuticals, Inc.盘中异动 大幅拉升7.17%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSupernus Pharmaceuticals, Inc.盘中异动 大幅拉升7.17%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-23 21:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232130317922ae9e&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年04月23日21时30分，Supernus Pharmaceuticals, Inc.（SUPN.us）股票出现异动，股价大幅拉升7.17%。截至发稿，该股报31.84美元/股，成交量847股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入6.08亿美元，净利润1.32百万美元，每股收益0.02美元，毛利4.39亿美元，市盈率1487.50倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232130317922ae9e&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232130317922ae9e&s=b","article_id":"2429185761","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232130317922ae9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2429185761","pubTimestamp":1713879030,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年04月23日21时30分，Supernus Pharmaceuticals, Inc.股票出现异动，股价大幅拉升7.17%。Supernus Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.78%。其相关个股中，Procaps Group, S.A.、Supernus Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.涨幅较大，Sunshine Biopharma Inc.、苏轩堂、Petros Pharmaceuticals, Inc.较为活跃，换手率分别为91.13%、4.20%、3.68%，振幅较大的相关个股有Supernus Pharmaceuticals, Inc.、Evotec Se、Canopy Growth Corporation，振幅分别为7.03%、2.58%、2.04%。Supernus Pharmaceuticals, Inc.公司简介：Supernus Pharmaceuticals Inc 是一家专业制药公司，致力于开发和商业化治疗包括神经和精神疾病在内的中枢神经系统疾病的产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","SUPN":"Supernus Pharmaceuticals"},"translate_title":"Supernus Pharmaceuticals, Inc. rose 7.17% in intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SUPN":1},"content_text":"北京时间2024年04月23日21时30分，Supernus Pharmaceuticals, Inc.（SUPN.us）股票出现异动，股价大幅拉升7.17%。截至发稿，该股报31.84美元/股，成交量847股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入6.08亿美元，净利润1.32百万美元，每股收益0.02美元，毛利4.39亿美元，市盈率1487.50倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Supernus Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.78%。其相关个股中，Procaps Group, S.A.、Supernus Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.涨幅较大，Sunshine Biopharma Inc.、苏轩堂、Petros Pharmaceuticals, Inc.较为活跃，换手率分别为91.13%、4.20%、3.68%，振幅较大的相关个股有Supernus Pharmaceuticals, Inc.、Evotec Se、Canopy Growth Corporation，振幅分别为7.03%、2.58%、2.04%。Supernus Pharmaceuticals, Inc.公司简介：Supernus Pharmaceuticals Inc 是一家专业制药公司，致力于开发和商业化治疗包括神经和精神疾病在内的中枢神经系统疾病的产品。 该公司多样化的神经科学产品组合包括癫痫、偏头痛、注意力缺陷多动障碍(ADHD)、帕金森病(PD)的运动障碍、宫颈肌张力障碍、慢性唾液分泌、PD患者接受左旋多巴治疗的运动障碍，以及成人患者药物诱导的锥体外系反应。公司产品包括 Trokendi XR、Oxtellar XR、Qelbree、APOKYN、XADAGO、MYOBLOC、GOCOVRI 和 Osmolex ER。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2429185761"}

Supernus Pharmaceuticals, Inc.盘中异动 大幅拉升7.17%

精彩评论

Supernus Pharmaceuticals, Inc.盘中异动大幅拉升7.17%